UNLABELLED: BACKROUND/AIMS: To analyze the prognostic value of gastric cancer surgery combined with splenectomy for gastric cancer patients. METHODOLOGY: Retrospective study was performed on 112 patients who underwent radical gastrectomy for upper third, upper and middle third, and entire stomach cancer, 61 patients underwent spleen-preserving modified radical lymphadenectomy (spleen-preservation group), and the remaining 51 patients underwent D2 radical lymphadenectomy with splenectomy (splenectomy group). Postoperative morbidity rate and the 5-year survival rate were compared. RESULTS: There was no significant difference between the spleen-preservation group and splenectomy group in gender, age, tumor size, T stage, N stage and TNM stage. The overall 5-year survival rate was 41.0% in the spleen-preservation group, compared with 39.2% in the splenectomy group (p>0.05). The 5-year survival rate of patients in the spleen-preservation group vs splenectomy group was 100% vs 100.0% for stage I, 66.7% vs 70.0% for stage II, 27.8% vs 26.7% for stage III, and 17.4% vs 5.6%for stage IV, respectively (p>0.05). There was a significant difference (p<0.05) in postoperative morbidity rate (11.5% for spleen-preservation group vs 27.5% in the splenectomy group). CONCLUSION: Lower postoperative morbidity but similar 5-year survival rate was observed in spleen-preserving modified radical lymphadenectomy group compared to D2 radical lymphadenectomy with splenectomy.
UNLABELLED: BACKROUND/AIMS: To analyze the prognostic value of gastric cancer surgery combined with splenectomy for gastric cancerpatients. METHODOLOGY: Retrospective study was performed on 112 patients who underwent radical gastrectomy for upper third, upper and middle third, and entire stomach cancer, 61 patients underwent spleen-preserving modified radical lymphadenectomy (spleen-preservation group), and the remaining 51 patients underwent D2 radical lymphadenectomy with splenectomy (splenectomy group). Postoperative morbidity rate and the 5-year survival rate were compared. RESULTS: There was no significant difference between the spleen-preservation group and splenectomy group in gender, age, tumor size, T stage, N stage and TNM stage. The overall 5-year survival rate was 41.0% in the spleen-preservation group, compared with 39.2% in the splenectomy group (p>0.05). The 5-year survival rate of patients in the spleen-preservation group vs splenectomy group was 100% vs 100.0% for stage I, 66.7% vs 70.0% for stage II, 27.8% vs 26.7% for stage III, and 17.4% vs 5.6%for stage IV, respectively (p>0.05). There was a significant difference (p<0.05) in postoperative morbidity rate (11.5% for spleen-preservation group vs 27.5% in the splenectomy group). CONCLUSION: Lower postoperative morbidity but similar 5-year survival rate was observed in spleen-preserving modified radical lymphadenectomy group compared to D2 radical lymphadenectomy with splenectomy.
Authors: Sander Van den Eede; Nick Van de Voorde; Filip Vanhoenacker; Bart Op de Beeck Journal: J Belg Soc Radiol Date: 2022-04-05 Impact factor: 1.894